Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
1. Oikonomopoulou K, Yu H, Wang Z, Vasiliou SK, Brinc D, Christofi G, et al. Association between Echinococcus granulosus infection and cancer risk – a pilot study in Cyprus. Clin Chem Lab Med 2016;54:1955–61.Search in Google Scholar
2. Akgül H, Tez M, Ünal AE, Keşkek M, Sayek İ, Özçelik T. Echinococcus against cancer: why not? Cancer 2003;98:1999–2000.Search in Google Scholar
3. Laubreton D, Bay S, Sedlik C, Artaud C, Ganneau C, Dériaud E, et al. The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity. Cancer Immunol Immunother 2016;65:315–25.Search in Google Scholar
4. Berriel E, Russo S, Monin L, Festari MF, Berois N, Fernández G, et al. Antitumor activity of human hydatid cyst fluid in a murine model of colon cancer. ScientificWorldJournal 2013;2013:230176.Search in Google Scholar
5. Lee AS. Glucose regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat Rev Cancer 2014;14:263–76.Search in Google Scholar
6. Daneshpour S, Bahadoran M, Hejazi SH, Eskandarian AA, Mahmoudzadeh M, Darani HY. Common antigens between hydatid cyst and cancers. Adv Biomed Res 2016;5:9.Search in Google Scholar
7. Sharafi SM, Rafiei R, Hadipour M, Shirzad H, Khanahmad H, Darani HY. A Nonglycosylated 27 kDa molecule as common antigen between human breast cancer and Echinococcus granulosus hydatid cyst wall. Adv Breast Cancer Res 2016;5:90.Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston